The pharmacokinetics of moxidectin following intravenous and topical administration to swine

被引:4
作者
Xiao, Hongzhi [1 ,2 ]
Peng, Haoyuan [1 ,2 ]
Zhao, Ting [1 ,2 ]
Kong, Jingyuan [1 ,2 ]
Xue, Jiao [1 ,2 ]
Wang, Jianzhong [1 ,2 ]
Lin, Yalong [1 ,2 ]
Zhang, Suxia [1 ,2 ]
Cao, Xingyuan [1 ,2 ,3 ]
机构
[1] China Agr Univ, Coll Vet Med, Dept Vet Pharmacol & Toxicol, Beijing, Peoples R China
[2] Minist Agr, Lab Qual & Safety Risk Assessment Anim Prod Chem, Beijing, Peoples R China
[3] Minist Agr, Key Lab Detect Vet Drug Residues & Illegal Addit, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
intravenous; moxidectin; pharmacokinetics; pour-on; swine; PLASMA DISPOSITION KINETICS; POUR-ON; IVERMECTIN; EFFICACY; FORMULATION; DORAMECTIN; ABOMASAL;
D O I
10.1111/jvp.12693
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pharmacokinetic parameters of moxidectin (MXD) after intravenous and pour-on (topical) administration were studied in sixteen pigs at a single dose of 1.25 and 2.5 mg/kg BW (body weight), respectively. Blood samples were collected at pretreatment time (0 hr) over 40 days. The plasma kinetics were analyzed by WinNonlin 6.3 software through a noncompartmental model. For intravenous administration (n = 8), the elimination half-life (lambda(Z)), the apparent volume of distribution (V-z), and clearance (Cl) were 10.29 +/- 1.90 days, 89.575 +/- 29.856 L/kg, and 5.699 +/- 2.374 L/kg, respectively. For pour-on administration (n = 8), the maximum plasma drug concentration (C-max), time to maximum plasma concentration (T-max), and lambda(Z) were 7.49 ng/ml, 1.72, and 6.20 days, respectively. MXD had a considerably low absolute pour-on bioavailability of 9.2%, but the mean residence time (MRT) for pour-on administration 10.88 +/- 1.75 days was longer than 8.99 +/- 2.48 days for intravenous administration. These results showed that MXD was absorbed via skin rapidly and eliminated slowly. The obtained data might contribute to refine the dosage regime for topical MXD administration.
引用
收藏
页码:111 / 115
页数:5
相关论文
共 50 条
[1]   Pharmacokinetics of moxidectin following topical administration to New Zealand rabbits [J].
Pan, B. ;
Wen, H. ;
Yang, Z. ;
Wang, F. ;
Wang, Z. ;
Wang, M. .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2011, 34 (01) :89-91
[2]   Pharmacokinetics of moxidectin in alpacas following administration of an oral or subcutaneous formulation [J].
Cocquyt, Christine M. ;
Van Amstel, Sarel ;
Cox, Sherry ;
Rohrbach, Barton ;
Martin-Jimenez, Tomas .
RESEARCH IN VETERINARY SCIENCE, 2016, 105 :160-164
[3]   Plasma dispositions of ivermectin, doramectin and moxidectin following subcutaneous administration in rabbits [J].
Gokbulut, C. ;
Biligili, A. ;
Kart, A. ;
Turgut, C. .
LABORATORY ANIMALS, 2010, 44 (02) :138-142
[4]   Plasma pharmacokinetics and faecal excretion of ivermectin, doramectin and moxidectin following oral administration in horses [J].
Gokbulut, C ;
Nolan, AM ;
McKellar, QA .
EQUINE VETERINARY JOURNAL, 2001, 33 (05) :494-498
[5]   Characterization of Moxidectin against Strongyloides ratti: In Vitro and In Vivo Activity and Pharmacokinetics in the Rat Model [J].
Buchter, Valentin ;
Hofmann, Daniela ;
Haeberli, Cecile ;
Keiser, Jennifer .
ACS INFECTIOUS DISEASES, 2021, 7 (05) :1069-1076
[6]   Comparison of the pharmacokinetics of moxidectin and ivermectin after oral administration to beagle dogs [J].
Al-Azzam, Sayer I. ;
Fleckenstein, Lawrence ;
Cheng, Kuei-Ju ;
Dzirnianski, Michael T. ;
McCall, John W. .
BIOPHARMACEUTICS & DRUG DISPOSITION, 2007, 28 (08) :431-438
[7]   Comparative pharmacokinetics of fluralaner in dogs and cats following single topical or intravenous administration [J].
Susanne Kilp ;
Diana Ramirez ;
Mark J Allan ;
Rainer KA Roepke .
Parasites & Vectors, 9
[8]   Comparative pharmacokinetics of fluralaner in dogs and cats following single topical or intravenous administration [J].
Kilp, Susanne ;
Ramirez, Diana ;
Allan, Mark J. ;
Roepke, Rainer K. A. .
PARASITES & VECTORS, 2016, 9
[9]   Midazolam pharmacokinetics following intravenous and buccal administration [J].
Schwagmeier, R ;
Alincic, S ;
Striebel, HW .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (03) :203-206
[10]   mTHPC pharmacokinetics following topical administration [J].
Johansson, Ann ;
Svensson, Jenny ;
Andersson-Engels, Stefan ;
Bendsoe, Niels ;
Svanberg, Katarina ;
Bigio, Irving ;
Alexandratou, Eleni ;
Kyriazi, Maria ;
Yova, Dido ;
Graefe, Susanna ;
Trebst, Tilmann .
Optical Diagnostics and Sensing VI, 2006, 6094 :C940-C940